Canada Biopharmaceutical Market Size & Outlook, 2024-2030

The biopharmaceutical market in Canada is expected to reach a projected revenue of US$ 35,513.6 million by 2030. A compound annual growth rate of 9.2% is expected of Canada biopharmaceutical market from 2025 to 2030.
Revenue, 2024 (US$M)
$21,213.9
Forecast, 2030 (US$M)
$35,513.6
CAGR, 2025 - 2030
9.2%
Report Coverage
Canada

Canada biopharmaceutical market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada biopharmaceutical market, 2018-2030 (US$M)

Canada biopharmaceutical market highlights

  • The Canada biopharmaceutical market generated a revenue of USD 21,213.9 million in 2024 and is expected to reach USD 35,513.6 million by 2030.
  • The Canada market is expected to grow at a CAGR of 9.2% from 2025 to 2030.
  • In terms of segment, monoclonal antibody was the largest revenue generating molecule type in 2024.
  • Hormone is the most lucrative molecule type segment registering the fastest growth during the forecast period.


Biopharmaceutical market data book summary

Market revenue in 2024USD 21,213.9 million
Market revenue in 2030USD 35,513.6 million
Growth rate9.2% (CAGR from 2025 to 2030)
Largest segmentMonoclonal antibody
Fastest growing segmentHormone
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMonoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone


Other key industry trends

  • In terms of revenue, Canada accounted for 4.7% of the global biopharmaceutical market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. biopharmaceutical market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 11,073.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharmaceutical Market Companies

Name Profile # Employees HQ Website

Canada biopharmaceutical market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical market will help companies and investors design strategic landscapes.


Monoclonal antibody was the largest segment with a revenue share of 67.81% in 2024. Horizon Databook has segmented the Canada biopharmaceutical market based on monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Canada biopharmaceutical market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada biopharmaceutical market databook

  • Our clientele includes a mix of biopharmaceutical market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada biopharmaceutical market , including forecasts for subscribers. This country databook contains high-level insights into Canada biopharmaceutical market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada biopharmaceutical market size, by molecule type, 2018-2030 (US$M)

Canada Biopharmaceutical Market Outlook Share, 2024 & 2030 (US$M)

Canada biopharmaceutical market size, by molecule type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more